Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OnabotulinumtoxinA in Base-of-thumb Osteoarthritis
NCT06902805Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2025
- Primary completion
- May 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in Osteoarthritis of the first carpometacarpal joint, sponsored by Assistance publique - Hôpitaux de Paris. Started Dec 2025; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
Osteoarthritis of the first carpometacarpal joint
Beyond the preview
Go deeper on NCT06902805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06902805.